Jump to main content

yr 〜
yr

Search results 2

Legislative and regulatory responses to the FTC study on barriers to entry in the pharmaceutical marketplace : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, June 17, 2003 Serial no. J-108-16 (United States. Congress. Senate. Committee on the Judiciary) (S. hrg. ; 108-250)

Legislative and regulatory responses to the FTC study on barriers to entry in the pharmaceutical marketplace : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, June 17, 2003 Serial no. J-108-16 (United States. Congress. Senate. Committee on the Judiciary) (S. hrg. ; 108-250)
Microform図書
2003<YCA-Y 4.J 89/2:S.HRG.108-250>
National Diet Library
  • Subject HeadingUnited States. Federal Trade Commission. -- Generic drug entry prior to patent expiration Drugs -- Generic substitution...

Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002

Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002
Microform図書
2002<YCA-Y 4.C 73/8:107-140>
National Diet Library
  • Subject HeadingUnited States. Federal Trade Commission. -- Generic drug entry prior to patent expiration Generic drugs -- Government p...

Reached to the end of result.

RSS